Compare Apple Inc (AAPL) vs CVS Health Corp (CVS) Price & Performance

AAPL trades at $304.91, down 2.69% over 24 hours, with a bearish technical signal. The stock shows strong fundamentals, including a 27.62% net income margin and consistent earnings beats. Recent news highlights Apple's leadership in smartphone shipments and AI potential through its 2.5 billion active devices, though it faces challenges like store closures and union disputes.

Outlook remains positive with a consensus price target of $337.63, but risks include competitive pressures, regulatory scrutiny from EU fines, and reliance on iPhone sales. Institutional sentiment is bullish, with 63.64% of analysts rating it Buy, supporting potential upside if earnings momentum continues.

CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.

The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.